Research News and Research

RSS

Groundbreaking discovery in lymphoma research

BC Cancer Agency scientists have discovered that a single gene, CIITA, is implicated in almost 40 per cent of primary mediastinal B-cell lymphomas and 15 per cent of all Hodgkin lymphoma cases.

3 Mar 2011

1099 repeal measure's pay-for mechanism triggers democratic concern

With a House vote scheduled for Thursday, the White House is on record opposing the "offset" used to pay for the repeal of this reporting provision included in the health law, but it also stopped short of threatening a veto. This part of the bill also may cause it to lose bipartisan support in the lower chamber.

3 Mar 2011

New study examines boxing injuries among children and adolescents from 1990 to 2008

The risk and nature of injury in the sport of boxing has generated a great deal of controversy in the medical community, especially in relation to youth boxing. A new study, conducted by researchers in the Center for Injury Research and Policy of The Research Institute at Nationwide Children's Hospital, examined boxing injuries among participants 6 years of age and older from 1990 to 2008.

3 Mar 2011

Vertex announces positive interim results from telaprevir Phase 2 study in patients with HCV, HIV

Vertex Pharmaceuticals Incorporated announced today interim results from an ongoing, two-part, Phase 2 study evaluating telaprevir in combination with pegylated-interferon and ribavirin compared to pegylated-interferon and ribavirin alone in people who are infected with both genotype 1 hepatitis C virus and human immunodeficiency virus, also known as HCV-HIV co-infection.

3 Mar 2011

Scientists discover bacterial communication mediated pathway

A pathway whereby bacteria communicate with each other has been discovered by researchers at the Hebrew University of Jerusalem. The discovery has important implications for efforts to cope with the spread of harmful bacteria in the body.

3 Mar 2011

Britain to cut foreign aid for 16 countries, focus more on family planning, safe water, maternal mortality

British Secretary of State for International Development Andrew Mitchell on Tuesday announced major changes to the nation's international aid program based on a nine-month review of the agency's policies, Reuters reports.

3 Mar 2011

FDA takes action against companies that manufacture unapproved prescription drugs

The U.S. Food and Drug Administration today took action against companies that manufacture, distribute, or market certain unapproved prescription oral cough, cold, and allergy products. The affected products cannot be legally marketed in the United States.

3 Mar 2011

Viewpoints: Obama's 'flexibility' offer; Virginia's abortion law 'mischief'; primary care cuts

President Obama had a splendid idea this week. He challenged governors who oppose his health care reforms, most of whom are Republicans, to come up with a better alternative.

3 Mar 2011

MicroConstants completes installation, qualification of new Xevo TQ-S tandem mass spectrometer

MicroConstants, Inc., a bioanalytical and pharmacokinetic-specialty Contract Research Organization in San Diego, California, announces today that it has successfully completed the installation and qualification of a new Xevo TQ-S tandem mass spectrometer from Waters Corporation.

3 Mar 2011

Study demonstrates neuronal loss during initial stages of HIV infection in mouse model

A new mouse model closely resembles how the human body reacts to early HIV infection and is shedding light on nerve cell damage related to the disease, according to researchers funded by the National Institutes of Health.

3 Mar 2011

Scientists discover genetic process that may allow ovarian cancer to resist chemotherapy

York University researchers have zeroed in on a genetic process that may allow ovarian cancer to resist chemotherapy.

3 Mar 2011

International consortium of researchers genetically characterise Spanish Fanconi anaemia patients

A consortium of thirty-two researchers worldwide, led by Dr Jordi Surrallés, professor of the Department of Genetics and Microbiology at Universitat Autònoma de Barcelona (UAB) and member of the Centre for Biomedical Network Research on Rare Diseases (CIBERER), genetically and clinically characterised almost all Spanish patients suffering from Franconi anaemia, a rare disease affecting one in every 500,000 persons and which is characterised by severe anaemia in children, congenital malformations and a high predisposition to cancer.

3 Mar 2011

Children with ASD can benefit from interactive computer program

Children with autism spectrum disorders are better able to recognize faces, facial expressions and emotions with the help of an interactive computer program called FaceSay, according to newly published research from psychologists at the University of Alabama at Birmingham.

3 Mar 2011

IBM announces new Patient Empowerment System

Today IBM announced the next evolution of the patient portal, significantly expanding the types of information, alerts, recommendations and interactive coaching healthcare providers can offer to their patients online.

3 Mar 2011

New breakthrough in immunological research

Immunological research at the University of Haifa, Israel, has made a new breakthrough, revealing a critical component in the "decision-making" process of white blood cells that play a role in the healing process from bacterial inflammation.

3 Mar 2011

U-M scientists identify potential target to treat aggressive prostate cancer

Researchers at the University of Michigan Comprehensive Cancer Center have identified a potential target to treat an aggressive type of prostate cancer. The target, a gene called SPINK1, could be to prostate cancer what HER2 has become for breast cancer.

3 Mar 2011

Corporations brace for health law gains and losses

Two corporations offer very different views of how changes resulting from the health overhaul will impact their bottom lines.

3 Mar 2011

ITI, Takeda collaborate to develop and commercialize PDE1 inhibitors for schizophrenia

Intra-Cellular Therapies, Inc. ("ITI") and Takeda Pharmaceutical Company Limited, today announced that they have entered into an exclusive collaboration to develop and commercialize selective phosphodiesterase type 1 (PDE1) inhibitors, discovered by ITI, for the treatment of cognitive impairment associated with schizophrenia. This agreement is targeted worldwide, but ITI has retained the option to co-promote with Takeda in the United States.

3 Mar 2011

Genetic variants determine severity of HCV-related graft disease and antiviral treatment response

German researchers have found a significant association of IL28B genotypes to interferon-based antiviral treatment outcome, and to graft inflammation caused by hepatitis C virus (HCV). The study determined that the presence of G-allele serves as a marker for severe HCV-induced graft inflammation, as well as a predictor for unsuccessful treatment.

3 Mar 2011

FADD protein discovery can lead to better cancer and autoimmune disease drugs

Reporting in Nature, scientists from Thomas Jefferson University have determined that a single protein called FADD controls multiple cell death pathways, a discovery that could lead to better, more targeted autoimmune disease and cancer drugs.

3 Mar 2011

Research News and Research

Groundbreaking discovery in lymphoma research

1099 repeal measure's pay-for mechanism triggers democratic concern

New study examines boxing injuries among children and adolescents from 1990 to 2008

Vertex announces positive interim results from telaprevir Phase 2 study in patients with HCV, HIV

Scientists discover bacterial communication mediated pathway

Britain to cut foreign aid for 16 countries, focus more on family planning, safe water, maternal mortality

FDA takes action against companies that manufacture unapproved prescription drugs

Viewpoints: Obama's 'flexibility' offer; Virginia's abortion law 'mischief'; primary care cuts

MicroConstants completes installation, qualification of new Xevo TQ-S tandem mass spectrometer

Study demonstrates neuronal loss during initial stages of HIV infection in mouse model

Scientists discover genetic process that may allow ovarian cancer to resist chemotherapy

International consortium of researchers genetically characterise Spanish Fanconi anaemia patients

Children with ASD can benefit from interactive computer program

IBM announces new Patient Empowerment System

New breakthrough in immunological research

U-M scientists identify potential target to treat aggressive prostate cancer

Corporations brace for health law gains and losses

ITI, Takeda collaborate to develop and commercialize PDE1 inhibitors for schizophrenia

Genetic variants determine severity of HCV-related graft disease and antiviral treatment response

FADD protein discovery can lead to better cancer and autoimmune disease drugs

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News